Overview

Study of the Effect of Food and a Proton Pump Inhibitor (PPI; Omeprazole) on LOXO-305 in Healthy Participants

Status:
Completed
Trial end date:
2020-03-23
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to learn about how food and a PPI (omeprazole) affect LOXO-305 in healthy participants. Participation could last about nine weeks.
Phase:
Phase 1
Details
Lead Sponsor:
Loxo Oncology, Inc.
Treatments:
Omeprazole